Hints and tips:
...Jigar Patel and his team wrote on Tuesday that they anticipate a pick-up in the usage of “GLP-1” drugs such as Ozempic over the next one to three years, which could eventually lead to a thinner population...
...But that was true last year as well, as Patel points out. So what’s different now?...
...“We’ve seen the CDX IG and CDX HY widen more than cash [in January],” says Jigar Patel, analyst at Barclays, referring to the US investment-grade and high-yield corporate bond derivatives indices operated...
International Edition